JP2005524627A5 - - Google Patents

Download PDF

Info

Publication number
JP2005524627A5
JP2005524627A5 JP2003562091A JP2003562091A JP2005524627A5 JP 2005524627 A5 JP2005524627 A5 JP 2005524627A5 JP 2003562091 A JP2003562091 A JP 2003562091A JP 2003562091 A JP2003562091 A JP 2003562091A JP 2005524627 A5 JP2005524627 A5 JP 2005524627A5
Authority
JP
Japan
Prior art keywords
dihydropyrimidine
oxo
methyl
ethynyl
trimethylsilyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003562091A
Other languages
English (en)
Japanese (ja)
Other versions
JP4498745B2 (ja
JP2005524627A (ja
Filing date
Publication date
Priority claimed from GBGB0201179.9A external-priority patent/GB0201179D0/en
Application filed filed Critical
Publication of JP2005524627A publication Critical patent/JP2005524627A/ja
Publication of JP2005524627A5 publication Critical patent/JP2005524627A5/ja
Application granted granted Critical
Publication of JP4498745B2 publication Critical patent/JP4498745B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003562091A 2002-01-18 2003-01-15 ピリミジノンウイルスポリメラーゼ阻害剤 Expired - Fee Related JP4498745B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0201179.9A GB0201179D0 (en) 2002-01-18 2002-01-18 Therapeutic agents
PCT/GB2003/000124 WO2003062211A1 (en) 2002-01-18 2003-01-15 Pyrimidinone viral polymerase inhibitors

Publications (3)

Publication Number Publication Date
JP2005524627A JP2005524627A (ja) 2005-08-18
JP2005524627A5 true JP2005524627A5 (https=) 2010-02-04
JP4498745B2 JP4498745B2 (ja) 2010-07-07

Family

ID=9929352

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003562091A Expired - Fee Related JP4498745B2 (ja) 2002-01-18 2003-01-15 ピリミジノンウイルスポリメラーゼ阻害剤

Country Status (8)

Country Link
US (1) US20050130997A1 (https=)
EP (1) EP1470113B1 (https=)
JP (1) JP4498745B2 (https=)
AT (1) ATE420078T1 (https=)
CA (1) CA2473508A1 (https=)
DE (1) DE60325692D1 (https=)
GB (1) GB0201179D0 (https=)
WO (1) WO2003062211A1 (https=)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004062613A2 (en) 2003-01-13 2004-07-29 Bristol-Myers Squibb Company Hiv integrase inhibitors
EP1658302B1 (en) 2003-07-25 2010-08-25 IDENIX Pharmaceuticals, Inc. Purine nucleoside analogues for treating diseases caused by flaviviridae including hepatitis c
AU2003304416A1 (en) * 2003-08-13 2005-03-07 Bf Research Institute, Inc. Probe for disease with amyloid deposit, amyloid-staining agent, remedy and preventive for disease with amyloid deposit and diagnostic probe and staining agent for neurofibril change
AR046938A1 (es) * 2003-12-12 2006-01-04 Merck & Co Inc Procedimiento para preparar hexahidropirimido[1,2-a]azepin-2-carboxilatos y compuetos similares
HRP20130971T1 (hr) 2004-02-20 2013-11-08 Boehringer Ingelheim International Gmbh Inhibitori virusne polimeraze
CA2606195C (en) 2005-05-02 2015-03-31 Merck And Co., Inc. Hcv ns3 protease inhibitors
AR057456A1 (es) 2005-07-20 2007-12-05 Merck & Co Inc Inhibidores de la proteasa ns3 del vhc
NZ565269A (en) 2005-08-01 2010-03-26 Merck & Co Inc Macrocyclic peptides as HCV NS3 protease inhibitors
CA2622639C (en) * 2005-10-04 2012-01-03 Istituto Di Recerche Di Biologia Molecolare P. Angeletti S.P.A. Hiv integrase inhibitors
GB0609492D0 (en) 2006-05-15 2006-06-21 Angeletti P Ist Richerche Bio Therapeutic agents
GB0612423D0 (en) 2006-06-23 2006-08-02 Angeletti P Ist Richerche Bio Therapeutic agents
AU2007309488B2 (en) 2006-10-24 2012-10-11 Merck Sharp & Dohme Corp. HCV NS3 protease inhibitors
CA2667146C (en) 2006-10-24 2016-01-19 Merck & Co., Inc. Hcv ns3 protease inhibitors
AU2007309546A1 (en) 2006-10-24 2008-05-02 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. HCV NS3 protease inhibitors
BRPI0718161A2 (pt) 2006-10-27 2013-11-26 Merck & Co Inc Composto, composição farmacêutica, e, uso do composto.
US8377874B2 (en) 2006-10-27 2013-02-19 Merck Sharp & Dohme Corp. HCV NS3 protease inhibitors
CA2672250C (en) 2006-12-20 2013-04-30 Ian Stansfield Antiviral indoles
GB0625345D0 (en) 2006-12-20 2007-01-31 Angeletti P Ist Richerche Bio Therapeutic compounds
GB0625349D0 (en) 2006-12-20 2007-01-31 Angeletti P Ist Richerche Bio Therapeutic compounds
ES2381410T3 (es) 2007-05-04 2012-05-28 Vertex Pharmceuticals Incorporated Terapia de combinación paa el tratamiento de infecciones por VHC
US7763630B2 (en) 2007-06-06 2010-07-27 Bristol-Myers Squibb Company HIV integrase inhibitors
JP2010533699A (ja) 2007-07-17 2010-10-28 イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー C型肝炎感染症の治療のための大環状インドール誘導体
AU2008277377B2 (en) 2007-07-19 2013-08-01 Msd Italia S.R.L. Macrocyclic compounds as antiviral agents
US8242140B2 (en) * 2007-08-03 2012-08-14 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
EP2234977A4 (en) 2007-12-19 2011-04-13 Boehringer Ingelheim Int VIRAL POLYMERASE INHIBITORS
WO2009134624A1 (en) 2008-04-28 2009-11-05 Merck & Co., Inc. Hcv ns3 protease inhibitors
EA019327B1 (ru) 2008-07-22 2014-02-28 Мерк Шарп Энд Домэ Корп. Макроциклическое хиноксалиновое соединение в качестве ингибитора протеазы вгс ns3
CN102271699A (zh) 2009-01-07 2011-12-07 西尼克斯公司 用于治疗hcv和hiv感染的环孢菌素衍生物
MX2011008276A (es) 2009-02-06 2011-12-14 Elan Pharm Inc Inhibidores de quinasa jun n-terminal.
US8143244B2 (en) 2009-02-26 2012-03-27 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
CA2755023C (en) * 2009-03-25 2016-12-13 Abbott Laboratories Antiviral compounds and uses thereof
US8828930B2 (en) 2009-07-30 2014-09-09 Merck Sharp & Dohme Corp. Hepatitis C virus NS3 protease inhibitors
US8383639B2 (en) 2009-10-15 2013-02-26 Bristol-Myers Squibb Company HIV integrase inhibitors
MX2013001273A (es) * 2010-08-13 2013-04-10 Hoffmann La Roche Compuestos heterociclicos antivirales.
WO2012151567A1 (en) * 2011-05-05 2012-11-08 St. Jude Children's Research Hospital Pyrimidinone compounds and methods for preventing and treating influenza

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2260319B (en) * 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
DE19817265A1 (de) * 1998-04-18 1999-10-21 Bayer Ag Verwendung von Dihydropyrimidinen als Arzneimittel und neue Stoffe
BR9913406A (pt) * 1998-09-04 2002-01-29 Viropharma Inc Processo de tratamento de infecção causada por pelo menos um vìrus da famìlia flaviviridae e de doença associada com a citada infecção em um hospedeiro vivo possuindo a citada infecção
GB0017676D0 (en) * 2000-07-19 2000-09-06 Angeletti P Ist Richerche Bio Inhibitors of viral polymerase

Similar Documents

Publication Publication Date Title
JP2005524627A5 (https=)
CN1209336C (zh) 生产2-卤代苯甲酸的方法
CN1582272A (zh) 制备5-(3-氰基苯基)-3-甲酰基苯甲酸化合物的方法
JP2011514871A5 (https=)
JP4377594B2 (ja) β−アルコキシプロピオンアミド類の製造方法
JP2008526897A5 (https=)
CN114573512B (zh) 一种合成c2-二氟烷基苯并咪唑衍生物的方法
JP2003212823A5 (https=)
CN101646643B (zh) 交叉偶联化合物的制造方法
CN106810444B (zh) 一种苯甲酰氯和卤代烷烃反应生成酯的方法
CN101061128A (zh) 制备二异丙基((1-(羟甲基)-环丙基)氧)甲基膦酸脂的方法
JPH051000A (ja) シクロヘキシル酪酸誘導体及びその製造法
US6498264B2 (en) Silyl (meth)acrylates having bulky substituent group and preparation thereof
CN1314673C (zh) 具有手性的多齿噁唑啉配体及其与主族金属或过渡金属的配合物、合成方法及其用途
JP5129699B2 (ja) メチル=ヘキサデカ−8−イノアートの製造方法
CN1642964A (zh) 铜络合物和利用该铜络合物形成含铜薄膜的方法
CN103249714B (zh) 山椒素类的制造方法
JP2004535444A5 (https=)
JP2003201281A (ja) 4−(2−メチル−1−イミダゾリル)−2,2−ジフェニルブタンアミドの製造方法
EP0371875A2 (en) Process for preparing 4-acetoxyazetidinones
CN115594621B (zh) 一种二硒醚类化合物的球磨机械化学合成方法
CN114181097A (zh) 一种盐酸甲氧明的合成方法
JP2005255660A (ja) 多官能基を有するラクタム類とその製法
JP3895053B2 (ja) ジハロメチルシラン類の製法
JP2002332289A (ja) 嵩高い置換基を有するシリル(メタ)アクリレート化合物及びその製造方法